Major Growth Boosting Factors:

Increasing R&D investments in the pharmaceutical and biotechnology industry is driving the growth of the market. Moreover, growth opportunities in emerging countries as well as the emergence of green chemistry,is likely to provide opportunities for the chiral chromatography column industry.

Expected Revenue Gains:

The chiral chromatography column market size is projected to reach USD 123 million by 2025 from an estimated USD 99 million in 2020, at a CAGR of 4.5% during the forecast period.

The pharmaceutical & biotechnology companies end-user segment is expected to grow at the highest CAGR from 2020 to 2025.

Pharmaceutical and biotechnology companies are among the key end-users of chiral chromatography columns.Increasing R&D for therapeutic areas, such as cancer, HIV/AIDS, and immunodeficiency disorders, technological innovations in biotechnology research, increasing focus of pharmaceutical and biotechnology companies on extending their product pipeline, rising number of drug discovery and clinical trial projects, and patent expiry of blockbuster drugs and biomolecules are some of the key factors driving the growth of this segment during the forecast period. Additionally, the availability of government and corporate funding for biotechnology and pharmaceutical research, growth of the pharmaceutical industry, and the presence of stringent regulatory guidelines for drug development and safety are other key factors driving the growth of this segment.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=225453435

Market Size Estimation:

Both top-down and bottom-up approaches have been used to estimate and validate the size of the chiral chromatography column market and its dependent submarkets. These methods were also used extensively to determine the extent of various sub-segments in the market. The research methodology used to estimate the market size includes the following:

# The key players in the industry and demand have been identified through extensive secondary research, and their market share has been determined through both primary and secondary research.
# The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation:

After arriving at the overall market size-using the market size estimation processes as explained above-the market was split into several segments and sub segments. To complete the whole market engineering process and arrive at the exact statistics of each market segment and sub segment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the end-use industries.

The metal based segment is expected to grow at the highest CAGR in the chiral chromatography column industry during the forecast period.

The increasing use of HPLC columns in academic institutes as well as in industries where high pressure is employed is likely to drive the market for stainless steel columns in the coming years. Agilent offers the SEC-5 HPLC columns packed with silica particles and coated with a neutral hydrophilic layer, which decreases sample-column interactions and improves peak capacity and resolution. Other prominent players in this market include Thermo Fisher Scientific, Inc., and Merck KGaA. Therefore, the high demand of metal-based columns in the pharmaceutical industry is expected to emerge as key revenue pockets for the metal-based columns in the chiral chromatography column market.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=225453435

The prepacked column is expected to grow at the highest CAGR during the forecast period.

Prepacked/ready-to-use columns are prefilled with the stationary phase and can directly be attached to chromatographic systems. Prepacked columns exhibit minimal variations and are uniform in nature. These columns are used for early method development for optimizing column packing. These columns are widely used in industries due to their ability to run large amounts of samples on a daily basis. Due to this, prepacked columns dominate the chiral chromatography columns market.

Chromatography columns are critical factors to the successful separation of valuable molecules. Pharmaceutical and biotechnology companies are extending their offering of standard, custom, and prepacked columns from lab-scale to pilot and process-scale. Prepacked large-scale columns meet the needs of manufacturing with single-use technologies.

Key Players:

To enable an in-depth understanding of the competitive landscape, the report includes the profiles of some of the top players in the chiral chromatography column market. The major players in the chiral chromatography column industry are Agilent Technologies (US), Thermo Fisher Scientific(US), Waters Corporation(US), Daicel Corporation (Japan), Bio-Rad Laboratories(US), W.R.Grace & Co. (US), Merk Group(Germany), GL Sciencies(Japan), Perkin Elmer (US), Shimadzu Corporation (Japan), Sartorious Group (Germany), Cytiva(US), ES Industruies (US), and Phenomenex (US)

These players are adopting various strategies to increase their share in the chiral chromatography column market. Contracts & agreements,new product launches, investments and expansions and mergers have been a widely adopted strategy by the major players in the chiral chromatography column industry.

Read the Detailed Research Report@
https://www.marketsandmarkets.com/Market-Reports/chiral-chromatogra...